Inactive Instrument

Project Sage Oldco, Inc.

Equities

SIEN

US82621J2042

Medical Equipment, Supplies & Distribution

Delayed OTC Markets Other stock markets 10:36:24 2024-06-28 EDT			5-day change	1st Jan Change
0.025 ^USD	-.--%		-.--%	-95.90%

06-18	Second Amended Liquidation Plan Approved for Sientra, Inc.	CI
06-13	Second Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.	CI

Sientra, Inc. Provides Preliminary Sales Guidance for the Fourth Quarter of 2017

January 08, 2018 at 08:16 am

Sientra, Inc. provided preliminary sales guidance for the fourth quarter of 2017. The company anticipates total revenue for the fourth quarter 2017 to be approximately $11.4 million, compared to total revenue for the fourth quarter 2016 of $6.5 million. Fourth quarter 2017 revenue expectations include anticipated segmented Breast Product revenue of $8.2 million and miraDry revenue of $3.2 million.

Latest news about Project Sage Oldco, Inc.

Second Amended Liquidation Plan Approved for Sientra, Inc.	06-18	CI
Second Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.	06-13	CI
First Motion for Exclusivity Period Extension Approved For Sientra, Inc.	06-10	CI
First Motion for Exclusivity Period Extension Filed by Sientra, Inc.	05-21	CI
Combined Hearing for Disclosure Statement and Plan Approved for Sientra, Inc.	05-08	CI
First Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.	05-07	CI
Tiger Aesthetics Medical, LLC acquired Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q).	04-23	CI
Reorganization Plan and Disclosure Statement Filed by Sientra, Inc.	04-15	CI
North American Morning Briefing : Stock Futures -2-	04-11	DJ
North American Morning Briefing : Focus Turns to -2-	04-04	DJ
Tiger Aesthetics Medical, LLC agreed to acquire Certain Assets from Sientra, Inc. (OTCPK:SIEN.Q) for $42.5 million.	04-01	CI
Motion for Asset Sale Filed by Sientra, Inc.	04-01	CI
Final DIP Financing Approved for Sientra, Inc.	03-11	CI
Bidding Procedure Approved for Sientra, Inc.	03-05	CI
Sientra, Inc.(OTCPK:SIEN.Q) dropped from NASDAQ Composite Index	02-20	CI
Sientra, Inc.(NasdaqGS:SIEN) dropped from S&P TMI Index	02-15	CI
Interim DIP Financing Approved for Sientra, Inc.	02-14	CI
Motion for Joint Administration Approved for Sientra, Inc.	02-13	CI
Health Care Limits Losses Amid Defensive Bias -- Health Care Roundup	02-13	DJ
Sientra Shares Plunge After Company Seeks Sale of Business, Files for Bankruptcy	02-13	MT
Motion for Asset Sale Filed by Sientra, Inc.	02-12	CI
Sientra to Pursue Strategic Sale of Its Business Through Voluntary Chapter 11 Process	02-12	CI
Motion for Joint Administration Filed by Sientra, Inc.	02-11	CI
Sientra, Inc. Filed for Bankruptcy	02-11	CI
Stifel Adjusts Price Target on Sientra to $2 From $4, Maintains Buy Rating	11-13	MT

Chart Project Sage Oldco, Inc.

Duration

Period

More charts

Company Profile

Project Sage Oldco Inc., formerly Sientra, Inc., is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-07 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-6.68%	179B
MEDTRONIC PLC	-5.20%	100B
BECTON, DICKINSON AND COMPANY	-5.38%	66.67B
HOYA CORPORATION	+18.16%	44.81B
DEXCOM, INC.	-6.47%	46.16B
CENCORA, INC.	+9.74%	44.38B
METTLER-TOLEDO INTERNATIONAL, INC.	+14.01%	29.53B
TERUMO CORPORATION	+22.31%	25.83B
WEST PHARMACEUTICAL SERVICES, INC.	-6.53%	23.97B

Other Medical Equipment, Supplies & Distribution